To clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law.
Summary
What This Bill Does
The bill requires findings Congress finds as follows: The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Public Law 115–176) was enacted in 2018 and requires amendment to Federal Right to Try law Section 561B(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. It relies on compliance mandates and definition changes. The main policy areas are Healthcare Consumers, Healthcare, and Transportation.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Transportation operators and users affected by the bill would take on compliance duties.
Key Provisions
- Requires findings Congress finds as follows: The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Public Law 115–176) was enacted in 2018.
- Requires amendment to Federal Right to Try law Section 561B(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires findings Congress finds as follows: The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Public Law 115–176) was enacted in 2018 and requires amendment to Federal Right to Try law Section 561B(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Key Policy Areas
Healthcare Consumers, Healthcare, Transportation
Primary Purpose
The bill requires findings Congress finds as follows: The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Public Law 115–176) was enacted in 2018 and requires amendment to Federal Right to Try law Section 561B(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Transportation operators and users affected by the bill
Sponsors
Legislative Progress
IntroducedMr. Blumenauer (for himself, Ms. Mace, Ms. Dean of Pennsylvania, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology